Latest Schedule 13G passive stakes

A group of investment funds managed by USV have collectively disclosed a 3.3% beneficial ownership stake in Teamshares Inc. common stock.

Paradigm BioCapital Advisors LP and affiliates have reported a 5.1% beneficial ownership stake in Viridian Therapeutics, Inc.

MMCAP International Inc. SPC and MM Asset Management Inc. have filed a Schedule 13G reporting a 6.5% beneficial ownership stake in Wilco 63 Corp.

Capital Ventures International, Susquehanna Advisors Group, and Susquehanna Securities have filed a Schedule 13G reporting an 11% beneficial ownership stake in Quantum eMotion Corp.

CVI Investments, Inc. and Heights Capital Management, Inc. have filed a Schedule 13G reporting a 5.5% beneficial ownership stake in CervoMed Inc.

Feis Equities LLC and Lawrence M. Feis have filed a Schedule 13G reporting a 5.08% beneficial ownership stake in Drugs Made In America Acquisition Corp.

Mountain Crest Holdings 6 LLC and Dr. Suying Liu report a 29.98% beneficial ownership stake in Mountain Crest Acquisition 6 Corp.

Millennium Management and affiliates report a reduction in their beneficial ownership of Horizon Quantum Holdings Ltd. shares to below the 5% threshold.

Baselake Partners, LP, Baselake Management, LLC, and David Paolella have filed a Schedule 13G reporting a 7.3% beneficial ownership stake in Passage Bio, Inc.

EcoR1 Capital, LLC and Oleg Nodelman have reported a 9% beneficial ownership stake in Fulcrum Therapeutics, Inc. via a Schedule 13G filing.

EcoR1 Capital, LLC and Oleg Nodelman have reported a 9% beneficial ownership stake in Fulcrum Therapeutics, Inc. via a Schedule 13G filing.

Millennium Management LLC and associated entities have filed a Schedule 13G disclosing they no longer hold a greater than 5% beneficial ownership stake in Xanadu Quantum Technologies Limited.

Les Filles, LLC, Tungsten III LLC, and Michael A. Parker have disclosed a 6.2% beneficial ownership stake in SRX Global Inc.

Avenue Venture Opportunities Fund II has amended its loan agreement with CalciMedica, maintaining a 4.99% ownership blocker.

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G reporting a 5.81% beneficial ownership stake in AstroNova, Inc.

Sculptor Capital LP and its affiliates have reported a 5.19% beneficial ownership stake in Wilco 63 Corporation.

Jane Street Group, LLC has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in Leslie's, Inc. common stock.

Point72 Asset Management and Steven A. Cohen have reported a 5.2% beneficial ownership stake in BlockchAIn Digital Infrastructure, Inc.

Helena Global Investment Opportunities 1 Ltd. has filed an exit notice, reporting zero beneficial ownership in DevvStream Corp.

MJL Manager LLC and Michael Liu have filed a Schedule 13G disclosing a combined beneficial ownership of 5.7% in Soligenix, Inc. common stock.

Dauntless Investment Group, LLC has filed a Schedule 13G reporting a 9.6% beneficial ownership stake in Azitra, Inc. common stock.

Private investor Peter J. Abrahamson has filed a Schedule 13G reporting beneficial ownership of 5.2% of Unifi, Inc. common stock.

GreenTech Investment Alliance Ltd. has filed a Schedule 13G reporting a 6.62% beneficial ownership stake in Ryde Group Ltd.

Pacific Ridge Capital Partners, LLC has filed an amendment to its Schedule 13G, reporting a 0% beneficial ownership stake in Sleep Number Corp.

Millennium Management LLC and Israel A. Englander have reported a 5.7% beneficial ownership stake in DXC Technology Company.

Jane Street Group, LLC has reported a 5.3% beneficial ownership stake in Ascent Solar Technologies, Inc. as of June 17, 2026.

Jane Street Group has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in Galaxy Digital Inc.

Paradigm BioCapital Advisors LP and associated entities have reported a 5.2% beneficial ownership stake in MBX Biosciences, Inc. as of June 16, 2026.

Individual investor Tai Wey Ann reports beneficial ownership of 100,000 shares of Aditxt, Inc. common stock.

S.H.N. Financial Investments Ltd. has filed a Schedule 13G reporting a 9.99% beneficial ownership stake in Tianci International, Inc.